Loading…
Revolution Medicines, Inc. is projected to rise to $242.09 by 2027, a +32% move from its current price of $183.86. RVMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $180.29 | $183.97 | $187.72 | +0.06% |
| Aug 1 | $178.89 | $184.08 | $189.41 | +0.12% |
| Aug 2 | $177.85 | $184.19 | $190.75 | +0.18% |
| Aug 3 | $177.00 | $184.30 | $191.90 | +0.24% |
| Aug 4 | $176.26 | $184.41 | $192.93 | +0.30% |
| Aug 5 | $175.61 | $184.52 | $193.88 | +0.36% |
| Aug 6 | $175.02 | $184.63 | $194.76 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $175.02 | $184.63 | $194.76 | +0.42% |
| Week 2 | $171.90 | $185.40 | $199.95 | +0.84% |
| Week 3 | $169.71 | $186.17 | $204.23 | +1.26% |
| Week 4 | $167.99 | $186.95 | $208.04 | +1.68% |
| Week 5 | $166.58 | $187.73 | $211.56 | +2.10% |
| Week 6 | $165.38 | $188.51 | $214.88 | +2.53% |
| Week 7 | $164.33 | $189.29 | $218.05 | +2.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Revolution Medicines, Inc. is a clinical-stage precision oncology company that develops novel targeted therapies for RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C).
Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
RVMD is the Revolution Medicines, Inc. stock, traded with a current price of $192.62 and a market cap of $40.95B. It ranks 347 by market cap among equities in its sector. The price outlook combines a solid near-term setup with a long-run bull case, as reflected in the multi-year forecast that envisions meaningful upside through 2030 and well beyond.
The forecast shows the average price rising over time, with increasingly large potential returns in later years.
A major floor 49.7% below — a decisive break under it would weaken the trend.
The nearest floor, 18.8% below — buyers have tended to step in here.
The nearest ceiling, 4.8% above — a clean break opens room to run.
A major ceiling 18.0% above — clearing it would confirm fresh momentum.
Key RVMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RVMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $186.47 | Sell | $186.96 | Sell |
| MA 10 | $184.75 | Sell | $185.84 | Sell |
| MA 20 | $186.82 | Sell | $182.83 | Buy |
| MA 50 | $168.45 | Buy | $169.45 | Buy |
| MA 100 | $143.53 | Buy | $149.49 | Buy |
| MA 200 | $112.69 | Buy | $121.80 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.28 | Neutral |
| Stoch RSI (14) | 33.74 | Neutral |
| CCI (20) | 28.68 | Neutral |
| Williams %R (14) | -25.61 | Info |
| MACD (12,26,9) | -1.02 | Sell |
| ROC (12) | -1.60 | Sell |
| Bollinger %B (20,2) | 0.59 | Neutral |
| Stochastic %K (14) | 74.39 | Neutral |
| TRIX (15) | 0.53 | Buy |
| Awesome (5,34) | 10.46 | Buy |
| Ultimate (7,14,28) | 62.34 | Neutral |
| Momentum (10) | 4.12 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 189.24 | Sell |
| ADX (14) | 25.09 | Buy |
| ATR (14) | 3.06 | Info |
In the near term, the technical picture is bullish with RSI14 at 80. The stock trades above the SMA50 of $152.10 and above the SMA200 of $99.26, suggesting constructive momentum.
The current price sits at a resistance level of $192.62, while a support level is noted at $144.19. The 30-day range spans from $162.11 to $228.88, indicating meaningful near-term volatility with potential for upside if buyers stay engaged. The security carries an annualized volatility of 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $78.33 | $183.86 | $248.30 | 0% | Neutral | |
| $197.60 | $242.09 | $310.58 | +32% | Bullish | |
| $230.66 | $288.39 | $380.79 | +57% | Bullish | |
| $257.68 | $327.58 | $442.43 | +78% | Bullish | |
| $288.28 | $371.86 | $511.91 | +102% | Bullish | |
| $361.18 | $472.08 | $660.83 | +157% | Bullish | |
| $432.05 | $571.65 | $812.32 | +211% | Bullish | |
| $489.28 | $654.78 | $943.26 | +256% | Bullish | |
| $525.35 | $710.66 | $1,036.75 | +287% | Bullish | |
| $540.68 | $738.93 | $1,090.73 | +302% | Bullish | |
| $941.04 | $1,346.44 | $2,088.41 | +632% | Bullish | |
| $2,010.34 | $3,105.33 | $5,182.29 | +15.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $78.33 | $183.86 | $215.16 | +0.00% |
| August 2026 | $160.00 | $186.84 | $222.59 | +1.62% |
| September 2026 | $165.22 | $194.10 | $233.51 | +3.89% |
| October 2026 | $169.71 | $200.35 | $242.92 | +3.22% |
| November 2026 | $168.92 | $200.22 | $244.30 | -0.07% |
| December 2026 | $170.07 | $202.32 | $248.30 | +1.05% |
Click any year to see its month-by-month RVMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Revolution Medicines, Inc.'s 2026 outlook centres on $183.86, within a $78.33 to $248.30 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, RVMD could reach as high as $310.58, with a base case around $242.09 and support toward $197.60 — roughly +32% from $183.86. Buyers look set to stay in control over this stretch.
Expect RVMD to range from $230.66 to $380.79 through 2028. The $288.39 average target implies a +57% move from current prices. That is up +19% on the projected 2027 average. Momentum favours further upside here.
The RVMD price prediction for 2029 points to an average of $327.58 (low $257.68, high $442.43) — a potential gain of +78% on today's $183.86. Buyers look set to stay in control over this stretch.
In 2030, RVMD is projected to trade between $288.28 and $511.91, averaging $371.86 — a potential gain of +102% from today's $183.86. That is up +14% on the projected 2029 average. Momentum favours further upside here.
Revolution Medicines, Inc.'s 2031 outlook centres on $472.08, within a $361.18 to $660.83 range. That is up +27% on the projected 2030 average. That marks a +157% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, RVMD could reach as high as $812.32, with a base case around $571.65 and support toward $432.05 — roughly +211% from $183.86. Momentum favours further upside here.
Expect RVMD to range from $489.28 to $943.26 through 2033. The $654.78 average target implies a +256% move from current prices. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The RVMD price prediction for 2034 points to an average of $710.66 (low $525.35, high $1,036.75) — a potential gain of +287% on today's $183.86. Momentum favours further upside here.
In 2035, RVMD is projected to trade between $540.68 and $1,090.73, averaging $738.93 — a potential gain of +302% from today's $183.86. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Revolution Medicines, Inc.'s 2040 outlook centres on $1,346.44, within a $941.04 to $2,088.41 range. That is up +82% on the projected 2035 average. That marks a +632% change versus current levels. Momentum favours further upside here.
By 2050, RVMD could reach as high as $5,182.29, with a base case around $3,105.33 and support toward $2,010.34 — roughly +15.9x from $183.86. Buyers look set to stay in control over this stretch.
Investing $1,000 in RVMD today (≈ 5.438921 RVMD) could be worth
$16,889.64
+$15,889.64 (+1589%) by 2050 · US Dollar
Based on the average projected RVMD price of $3,105.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RVMDwould be worth at today's price.
$1,000 invested in RVMD on Jul 28, 2025 (≈ 26.838434 RVMD) would be worth
$4,934.51
+$3,934.51 (+393.5%) today · 4.93× · US Dollar
Based on a RVMD entry price of $37.26 vs. today's $183.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $180.39 | $1,019.24 | +1.9% |
| 1 month ago | $182.08 | $1,009.78 | +1.0% |
| 3 months ago | $144.83 | $1,269.49 | +26.9% |
| 6 months ago | $97.33 | $1,889.04 | +88.9% |
| 1 year ago | $37.26 | $4,934.51 | +393.5% |
| All time (5.0y) ago | $29.34 | $6,266.53 | +526.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RVMD forecast.
Our base-case forecast reaches $370.00 around 2030.
Implied market cap at $370.00: $78.66B
The multi-year forecast shows a bullish trajectory with the 2026 avg price at $192.62 and then substantial upside thereafter. By 2030, the avg price is projected at $357.12 with a max of $515.34 and a min of $266.48, for an ROI of 85.4% and bullish sentiment.
In 2040, the forecast envisions an avg price of $1,228.85, a max of $2,049.54, a min of $796.06, and an ROI of 538 with bullish sentiment continuing.
By 2050, the avg price is projected to $2,875.86, with a max of $5,234.24, a min of $1,671.52, and an ROI of 1393, sustaining a bullish outlook. These figures are estimates and not guarantees, and they reflect potential upside under the assumed conditions of the forecast.
Tap a question to reveal the answer.
Avg $357.12; min $266.48; max $515.34; ROI 85.4; sentiment bullish.
Forecast data show bullish sentiment from 2027 onward with rising avg prices and ROIs (e.g., 2027 avg $249.33, ROI 29.4; 2030 avg $357.12, ROI 85.4; 2040 avg $1,228.85, ROI 538; 2050 avg $2,875.86, ROI 1393). These are estimates, not guarantees.
Yes, the 2030 forecast max is $515.34, which exceeds $500.
Current price is $192.62; market cap is $40.95B.
RSI14 is 80; 30-day range low $162.11, high $228.88; Support $144.19; Resistance $192.62; SMA50 $152.10; SMA200 $99.26.
Revolution Medicines, Inc. Community Discussion
0Share your Revolution Medicines, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.